SCHEMBL25974052

SCHEMBL25974052

C[S+]([O-])c1ccc(-c2cccnc2Nc2ccc(C(F)(F)F)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 9/20 0.44
▸ EPHX2 P34913 5/20 0.44
▸ ABCG2 Q9UNQ0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25974049 0.85 EPHX2 (0.42) TRPV1EPHX2
SCHEMBL25973155 0.80 TP53 (0.41) EPHX2
SCHEMBL25974134 0.79 TNNI3K (0.50) TRPV1EPHX2
SCHEMBL25341064 0.77 TRPV1 (0.50) TRPV1EPHX2
SCHEMBL25973840 0.77 PDE10A (0.47) —
SCHEMBL25341133 0.76 MKNK1 (0.51) TRPV1EPHX2
SCHEMBL25376256 0.76 KCNQ3 (0.48) TRPV1EPHX2
SCHEMBL25378193 0.76 ABCG2 (0.47) TRPV1EPHX2ABCG2
SCHEMBL25974136 0.74 EPHX2 (0.48) TRPV1EPHX2
SCHEMBL25974137 0.74 TRPV1 (0.49) TRPV1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023146513-A1 COMPOUNDS AND METHODS OF USE THEREOF VIVACE THERAPEUTICS, INC. (US) 2023-08-03 — — WO disclosed
Send feedback